AMS Fact Sheet – Menopause before 40 and spontaneous premature ovarian insufficiency Banner

AMS Fact Sheet – Menopause before 40 and spontaneous premature ovarian insufficiency

Categories: , , ,

Menopause before 40 and spontaneous premature ovarian insufficiency (POI)

MAIN POINTS
  • Premature ovarian insufficiency (POI) is a loss of function of the ovaries in women who are less than 40 years old.
  • Spontaneous POI affects up to 4% of women less than 40 years and in most cases the cause is not identified.
  • Irregular/no menstrual periods or menopausal symptoms may be the only sign of POI and blood tests are needed for diagnosis.
  • POI can cause infertility and increase the risk of long-term health problems such as heart disease and osteoporosis.
  • Hormone replacement therapy is recommended until the usual age of menopause (around 51 years) to reduce the long-term risks.
  • Speak with your doctor about treatments and other options to manage any infertility and health consequences.
Learn More & Download the Fact Sheet

 

 

Latest News


Reasons for PBAC denial of women’s testosterone therapy released: “inequitable” and “scientifically flawed” Reasons for PBAC denial of women’s testosterone therapy released: “inequitable” and “scientifically flawed”

MEDIA RELEASE – Embargo 12.00 am, 27 March 2026 Reasons for PBAC denial of women’s testosterone therapy released: “inequitable” and “scientifically flawed” Last Friday,… Continue Reading →

AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT

MEDIA RELEASE – Wed 11 February 2026 AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT A small Perth-based pharmaceutical company is stepping up… Continue Reading →